Cspc Pharmaceutical Group
(OTC) CHJTF
Cspc Pharmaceutical Group Financials at a Glance
Market Cap
$11.75B
Revenue (TTM)
$46.62B
Net Income (TTM)
$6.41B
EPS (TTM)
$0.05
P/E Ratio
21.70
Dividend
$0.03
Beta (Volatility)
0.03 (Low)
Dividend
$0.03
Beta (Volatility)
0.03 (Low)
Price
$1.02
Volume
400
Open
$1.02
Price
$1.02
Volume
400
Open
$1.02
Previous Close
$1.02
Daily Range
$1.02 - $1.02
52-Week Range
$0.64 - $1.39
Dividend
$0.03
Beta (Volatility)
0.03 (Low)
Price
$1.02
Volume
400
Open
$1.02
Previous Close
$1.02
Daily Range
$1.02 - $1.02
52-Week Range
$0.64 - $1.39
CHJTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cspc Pharmaceutical Group
Industry
Pharmaceuticals
Sector
Health CareEmployees
19,700
CEO
Lei Cai, PhD
Website
www.cspc.com.hkHeadquarters
Shijiazhuang, 050035, CN
CHJTF Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
15%
Net Income Margin
15%
Return on Equity
12%
Return on Capital
11%
Return on Assets
8%
Earnings Yield
4.61%
Dividend Yield
0.03%
Payout Ratio
44.03%
Stock Overview
Market Cap
$11.75B
Shares Outstanding
11.52B
Volume
400
Short Interest
0.00%
Avg. Volume
816.581
Financials (TTM)
Gross Profit
$18.50B
Operating Income
$4.31B
EBITDA
$5.83B
Operating Cash Flow
$4.53B
Capital Expenditure
$2.68B
Free Cash Flow
$1.86B
Cash & ST Invst.
$9.87B
Total Debt
$713.91M
Cspc Pharmaceutical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.94B
+83.7%
Gross Profit
$9.14B
-51.1%
Gross Margin
65.57%
N/A
Market Cap
$11.75B
N/A
Market Cap/Employee
$549.20K
N/A
Employees
21,400
N/A
Net Income
$1.46B
+5.9%
EBITDA
$2.32B
+29.8%
Quarterly Fundamentals
Net Cash
$9.16B
-26.1%
Accounts Receivable
$10.63B
+5.0%
Inventory
$3.44B
-0.3%
Long Term Debt
$201.21M
+87.9%
Short Term Debt
$512.70M
-14.5%
Return on Assets
8.07%
N/A
Return on Invested Capital
10.56%
N/A
Free Cash Flow
$287.78M
-34.3%
Operating Cash Flow
$452.37M
-70.0%